Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,580 public trials 828 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Active, Not Recruiting

A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma

NCT05675449

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Clinical Research Advisors (Encino Satellite Location) Encino, California, United States
  • Clinical Research Advisors (Korea Town Satellite Location) Los Angeles, California, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients

NCT06062537

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHU Amiens Picardie Amiens, France
  • CH d'ANNECY Annecy, France
  • Centre hospitalier d'Argenteuil Argenteuil, France
  • Hopital de la cote Basque Bayonne, France
View all 31 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

NCT05572515

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
View all 211 locations
View Trial Details
Active, Not Recruiting

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

NCT05955508

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Hospital Clinico Universitario Santiago de Compostela Santiago de Compostela, A Coruna, Spain
  • Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain
  • Hospital Universitari Son Llatzer Palma Mallorca, Balearic Islands, Spain
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
View all 17 locations
View Trial Details
Active, Not Recruiting

Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma

NCT05208086

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Ch Annecy Genevois Annecy, France
  • Centre Hospitalier Métropole de Savoie Chambéry, France
  • CHU François Mitterand Dijon, France
  • CH de Dunkerque Dunkirk, France
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

NCT05885555

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Med Center Boston, Massachusetts, United States
  • Novartis Investigative Site CABA, Argentina
  • Novartis Investigative Site Garran, Australian Capital Territory, Australia
View all 24 locations
View Trial Details

Related conditions